• Work With Us
    • Partnerships
      • We offer tailored partnerships to support and transform drug discovery.

        Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

    • Services
      • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

        As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

    • OrganoReady®
      • Our OrganoReady program is made for you when you need defined assays in ADME.

        We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Resources & Support
    • Knowledge Center
      • Get inspired by peer-reviewed publications, webinars, whitepapers, app notes and more in our knowledge center.

    • Blogs
      • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
    • Case Studies
      • Get inspired by research done by our scientists, partners, and customers around the globe.

    • Webinars & Events
    • Applications
  • About MIMETAS
  • News
  • We offer tailored partnerships to support and transform drug discovery.

    Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

  • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

    As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

  • Our OrganoReady program is made for you when you need defined assays in ADME.

    We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Get inspired by peer-reviewed publications, webinars, whitepapers, app notes and more in our knowledge center.

  • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
open menu icon close menu icon
EN

Neutrophilic Infiltration in Organ-on-a-Chip Model of Tissue Inflammation

On-Demand Webinar

Inflammatory diseases are difficult to model efficiently and the translation of therapeutic findings into patients is particularly challenging. One of the reasons for this is the fundamental difference that exists in the immunological response between different laboratory animals. In this webinar Dr. Nikolce Gjorevski (Roche) will present a human-relevant organ-on-a-chip model to investigate the onset of inflammatory diseases.

This in vitro gut model is the first one to incorporate a mucosal barrier, a three-dimensional extracellular matrix (ECM) and resident and infiltrating immune cells. Because of the functional crosstalk between these components, cellular processes are triggered that are representative of inflammation. With this model the onset of tissue inflammation can be investigated in a reproducible, efficient, controlled and human-relevant system.

Register Here

Speaker

Dr. Nikolce Gjorevski, Principal Scientist
Nikolce received an undergraduate degree in chemical engineering at Lafayette College, after which he obtained his PhD in chemical and biological engineering at Princeton University. He used novel tissue microfabrication approaches to quantitatively study mammary gland development and disease. Continuing his career Dr. Nikolce Gjorevski received an EMBO Long-Term Postdoctoral Fellowship to work in the group of Matthias Lutolf at EPFL, Laussanne. He began as a senior scientist at Roche, where he aims to establish advanced cellular models and microphysiological systems as platforms for drug discovery.


Related publications

Cookies

‘May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below. Terms of Use & Privacy Policy

Accept all
Accept selected
Decline all